Molecular Characterization of TET2 in Cytogenetically Normal Acute Myeloid Leukemia

被引：0
|
作者：
Lee, J. [1 ,2 ]
Jun, K. [2 ]
Song, S. [2 ]
Oh, S. [1 ]
Shin, J. [1 ]
Kim, H. [1 ]
Lee, J. [1 ,2 ]
机构：
[1] Inje Univ, Busan Paik Hosp, Pusan, South Korea
[2] Haeundae Paik Hosp, Pusan, South Korea
来源：
JOURNAL OF MOLECULAR DIAGNOSTICS | 2013年 / 15卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：858 / 858
页数：1
相关论文
共 50 条
  • [21] TET2 MUTATIONS OCCUR IN OVER 20% OF ADULTS WITH DE NOVO CYTOGENETICALLY NORMAL ACUTE MYELOID LEUKEMIA, AND THEIR PREVALENCE INCREASES WITH AGE: A CANCER AND LEUKEMIA GROUP B STUDY
    Metzeler, K.
    Maharry, K.
    Margeson, D.
    Curfman, J.
    Becker, H.
    Radmacher, M.
    Mrozek, K.
    Holland, K.
    Whitman, S.
    Wu, Y.
    Schwind, S.
    Blum, W.
    Powell, B.
    Carter, T.
    Baer, M.
    Carroll, A.
    Kolitz, J.
    Caligiuri, M.
    Larson, R.
    Marcucci, G.
    Bloomfield, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 12 - 13
  • [22] TET2 gene mutation is unfavorable prognostic factor in cytogenetically normal acute myeloid leukemia patients with NPM1+ and FLT3-ITD− mutations
    Xiaopeng Tian
    Yang Xu
    Jia Yin
    Hong Tian
    Suning Chen
    Depei Wu
    Aining Sun
    International Journal of Hematology, 2014, 100 : 96 - 104
  • [23] TET2 gene mutation is unfavorable prognostic factor in cytogenetically normal acute myeloid leukemia patients with NPM1+ and FLT3-ITD- mutations
    Tian, Xiaopeng
    Xu, Yang
    Yin, Jia
    Tian, Hong
    Chen, Suning
    Wu, Depei
    Sun, Aining
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2014, 100 (01) : 96 - 104
  • [24] ACQUIRED MUTATIONS IN TET2 ARE COMMON IN MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIA
    Langemeijer, S. M. C.
    Kuiper, R. P.
    Berends, M.
    Knops, R.
    Aslanyan, M. G.
    Massop, M.
    Stevens-Linders, E.
    van Hoogen, P.
    van Kessel, A. Geurts
    Raymakers, R. A. P.
    Kamping, E. J.
    Verhoef, G. E.
    Verburgh, E.
    Hagemeijer, A.
    Vandenberghe, P.
    de Witte, T.
    van der Reijden, B. A.
    Jansen, J. H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 197 - 197
  • [25] MicroRNA expression in cytogenetically normal acute myeloid leukemia
    Marcucci, Guido
    Radmacher, Michael D.
    Maharry, Kati
    Mrozek, Krzysztof
    Ruppert, Amy S.
    Paschka, Peter
    Vukosavljevic, Tamara
    Whitman, Susan P.
    Baldus, Claudia D.
    Langer, Christian
    Liu, Chang-Gong
    Carroll, Andrew J.
    Powell, Bayard L.
    Garzon, Ramiro
    Croce, Carlo M.
    Kolitz, Jonathan E.
    Caligiuri, Michael A.
    Larson, Richard A.
    Bloomfield, Clara D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (18): : 1919 - 1928
  • [26] Biallelic TET2 mutations confer sensitivity to 5′-azacitidine in acute myeloid leukemia
    Stoelzel, Friedrich
    Fordham, Sarah E.
    Nandana, Devi
    Lin, Wei-Yu
    Blair, Helen
    Elstob, Claire
    Bell, Hayden L.
    Mohr, Brigitte
    Ruhnke, Leo
    Kunadt, Desiree
    Dill, Claudia
    Allsop, Daniel
    Piddock, Rachel
    Soura, Emmanouela-Niki
    Park, Catherine
    Fadly, Mohd
    Rahman, Thahira
    Alharbi, Abrar
    Wobus, Manja
    Altmann, Heidi
    Roellig, Christoph
    Wagenfuehr, Lisa
    Jones, Gail L.
    Menne, Tobias
    Jackson, Graham H.
    Marr, Helen J.
    Fitzgibbon, Jude
    Onel, Kenan
    Meggendorfer, Manja
    Robinson, Amber
    Bziuk, Zuzanna
    Bowes, Emily
    Heidenreich, Olaf
    Haferlach, Torsten
    Villar, Sara
    Ariceta, Benat
    Diaz, Rosa Ayala
    Altschuler, Steven J.
    Wu, Lani F.
    Prosper, Felipe
    Montesinos, Pau
    Martinez-Lopez, Joaquin
    Bornhaeuser, Martin
    Allan, James M.
    JCI INSIGHT, 2023, 8 (02)
  • [27] Loss of TET2 Increases MHC Class I Expression in Acute Myeloid Leukemia
    Gu, Xiaorong
    Bae, Songa
    Zhang, Yahan
    Williams, Nakisha
    Jiang, Dongxu
    Schlanger, Simon
    Visconte, Valeria
    Maciejewski, Jaroslaw
    Jha, Babal K.
    BLOOD, 2024, 144 : 4159 - 4160
  • [28] Reduced TET2 expression in Patients with Myelodysplastic Syndromes and Acute Myeloid Leukemia.
    Scopim-Ribeiro, Renata
    Machado-Neto, Joao
    Campos, Paula de Melo
    Favaro, Patricia
    Duarte, Adriana S. S.
    Visconte, Valeria
    Lorand-Metze, Irene
    Costa, Fernando Ferreira
    Maciejewski, Jaroslaw P.
    Tiu, Ramon V.
    Olalla Saad, Sara T.
    Traina, Fabiola
    BLOOD, 2012, 120 (21)
  • [29] TET2 mutations in acute myeloid leukemia: a comprehensive study in patients of Sindh, Pakistan
    Shaikh, Abdul Rehman Khalil
    Ujjan, Ikram
    Irfan, Muhammad
    Naz, Arshi
    Shamsi, Tahir
    Khan, Muhammad Tariq Masood
    Shakeel, Muhammad
    PEERJ, 2021, 9
  • [30] TET2 mutation in acute myeloid leukemia: biology, clinical significance, and therapeutic insights
    Gao, Qiang
    Shen, Kefeng
    Xiao, Min
    CLINICAL EPIGENETICS, 2024, 16 (01)
12345